US 12,226,390 B2
Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
Samuel C. Fortin, Sainte-Luce (CA)
Assigned to SCF PHARMA INC., Sainte-Luce (CA)
Filed by SCF PHARMA INC., Sainte-Luce (CA)
Filed on May 19, 2023, as Appl. No. 18/199,797.
Application 18/199,797 is a continuation of application No. 17/269,253, abandoned, previously published as PCT/CA2020/051007, filed on Jul. 21, 2020.
Application 17/269,253 is a continuation in part of application No. 16/517,607, filed on Jul. 21, 2019, granted, now 10,716,776, issued on Jul. 21, 2020.
Application 17/269,253 is a continuation in part of application No. 16/910,055, filed on Jun. 23, 2020, granted, now 11,478,443, issued on Oct. 25, 2022.
Application 16/517,607 is a continuation of application No. 16/517,607, filed on Jul. 21, 2019, granted, now 10,716,776, issued on Jul. 21, 2020.
Claims priority of provisional application 62/886,400, filed on Aug. 14, 2019.
Prior Publication US 2023/0355564 A1, Nov. 9, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/232 (2006.01); A61K 31/05 (2006.01); A61K 31/192 (2006.01); A61K 31/352 (2006.01); A61K 35/60 (2006.01); A61K 36/185 (2006.01)
CPC A61K 31/232 (2013.01) [A61K 31/05 (2013.01); A61K 31/192 (2013.01); A61K 31/352 (2013.01); A61K 35/60 (2013.01); A61K 36/185 (2013.01)] 12 Claims
 
1. A composition consisting essentially of:
a synthetic SN1 monoglyceride selected from the group consisting of a compound of formula (I), a compound of formula (II), a compound of formula (III), a compound of formula (IV) and mixtures thereof:

OG Complex Work Unit Chemistry
a SN 1,2 synthetic diglyceride;
a SN 1,3 synthetic diglyceride; and
an isolated cannabinoid selected from the group consisting of an isolated Cannabidiol (CBD), an isolated Cannabidiolic Acid (CBDA), an isolated Tetrahydrocannabinol (THC) and mixtures thereof.